Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2010
We read with interest the article by Rogers and colleagues titled “Prospective Randomized Trial of LC + LCBDE vs ERCP/S + LC for Common Bile Duct Stone Disease.”1 The authors are to be commended for undertaking and reporting on a randomized study in an area in which clinical practice in selecting between these 2 therapeutic options is currently largely dictated by institutional expertise and individual physician preference, as opposed to outcome data from controlled studies.
Yachimski P, Poulose BK. ERCP vs Laparoscopic Common Bile Duct Exploration for Common Bile Duct Stones: Are the 2 Techniques Truly Equivalent?. Arch Surg. 2010;145(8):795. doi:10.1001/archsurg.2010.126